166 related articles for article (PubMed ID: 38305126)
1. Defining the need for cardiovascular event definitions.
Bhatty A; Wilkinson C; Sydes M; Gale CP
Eur Heart J Qual Care Clin Outcomes; 2024 Mar; 10(2):105-107. PubMed ID: 38305126
[No Abstract] [Full Text] [Related]
2. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Hicks KA; Mahaffey KW; Mehran R; Nissen SE; Wiviott SD; Dunn B; Solomon SD; Marler JR; Teerlink JR; Farb A; Morrow DA; Targum SL; Sila CA; Hai MTT; Jaff MR; Joffe HV; Cutlip DE; Desai AS; Lewis EF; Gibson CM; Landray MJ; Lincoff AM; White CJ; Brooks SS; Rosenfield K; Domanski MJ; Lansky AJ; McMurray JJV; Tcheng JE; Steinhubl SR; Burton P; Mauri L; O'Connor CM; Pfeffer MA; Hung HMJ; Stockbridge NL; Chaitman BR; Temple RJ;
Circulation; 2018 Feb; 137(9):961-972. PubMed ID: 29483172
[TBL] [Abstract][Full Text] [Related]
3. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Hicks KA; Mahaffey KW; Mehran R; Nissen SE; Wiviott SD; Dunn B; Solomon SD; Marler JR; Teerlink JR; Farb A; Morrow DA; Targum SL; Sila CA; Thanh Hai MT; Jaff MR; Joffe HV; Cutlip DE; Desai AS; Lewis EF; Gibson CM; Landray MJ; Lincoff AM; White CJ; Brooks SS; Rosenfield K; Domanski MJ; Lansky AJ; McMurray JJV; Tcheng JE; Steinhubl SR; Burton P; Mauri L; O'Connor CM; Pfeffer MA; Hung HMJ; Stockbridge NL; Chaitman BR; Temple RJ;
J Am Coll Cardiol; 2018 Mar; 71(9):1021-1034. PubMed ID: 29495982
[TBL] [Abstract][Full Text] [Related]
4. Finding a consensus on time-to-event endpoints definitions in marginal zone lymphoma: A Delphi method.
Bommier C; Lambert J; Nowakowski G; Zucca E; Thieblemont C
Hematol Oncol; 2022 Dec; 40(5):1086-1089. PubMed ID: 35299287
[TBL] [Abstract][Full Text] [Related]
5. Relationships of different types of event to cardiovascular death in trials of antihypertensive treatment: an aid to definition of total cardiovascular disease risk in hypertension.
Zambon A; Arfè A; Corrao G; Zanchetti A
J Hypertens; 2014 Mar; 32(3):495-508. PubMed ID: 24378997
[TBL] [Abstract][Full Text] [Related]
6. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review.
Bosco E; Hsueh L; McConeghy KW; Gravenstein S; Saade E
BMC Med Res Methodol; 2021 Nov; 21(1):241. PubMed ID: 34742250
[TBL] [Abstract][Full Text] [Related]
7. Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.
Bellera CA; Pulido M; Gourgou S; Collette L; Doussau A; Kramar A; Dabakuyo TS; Ouali M; Auperin A; Filleron T; Fortpied C; Le Tourneau C; Paoletti X; Mauer M; Mathoulin-Pélissier S; Bonnetain F
Eur J Cancer; 2013 Mar; 49(4):769-81. PubMed ID: 23122780
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and consensus definitions for the Standardized Endpoints in Perioperative Medicine (StEP) initiative: cardiovascular outcomes.
Beattie WS; Lalu M; Bocock M; Feng S; Wijeysundera DN; Nagele P; Fleisher LA; Kurz A; Biccard B; Leslie K; Howell S; Landoni G; Grocott H; Lamy A; Richards T; Myles P; ; ; ; ; ; ; ; ; ; ; ; ; ;
Br J Anaesth; 2021 Jan; 126(1):56-66. PubMed ID: 33092804
[TBL] [Abstract][Full Text] [Related]
10. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.
Lansky AJ; Messé SR; Brickman AM; Dwyer M; van der Worp HB; Lazar RM; Pietras CG; Abrams KJ; McFadden E; Petersen NH; Browndyke J; Prendergast B; Ng VG; Cutlip DE; Kapadia S; Krucoff MW; Linke A; Moy CS; Schofer J; van Es GA; Virmani R; Popma J; Parides MK; Kodali S; Bilello M; Zivadinov R; Akar J; Furie KL; Gress D; Voros S; Moses J; Greer D; Forrest JK; Holmes D; Kappetein AP; Mack M; Baumbach A
J Am Coll Cardiol; 2017 Feb; 69(6):679-691. PubMed ID: 28183511
[TBL] [Abstract][Full Text] [Related]
11. Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.
Psaty BM; Delaney JA; Arnold AM; Curtis LH; Fitzpatrick AL; Heckbert SR; McKnight B; Ives D; Gottdiener JS; Kuller LH; Longstreth WT
Circulation; 2016 Jan; 133(2):156-64. PubMed ID: 26538580
[TBL] [Abstract][Full Text] [Related]
12. The scoring of respiratory events in sleep: reliability and validity.
Redline S; Budhiraja R; Kapur V; Marcus CL; Mateika JH; Mehra R; Parthasarthy S; Somers VK; Strohl KP; Sulit LG; Gozal D; Wise MS; Quan SF
J Clin Sleep Med; 2007 Mar; 3(2):169-200. PubMed ID: 17557426
[TBL] [Abstract][Full Text] [Related]
13. Need for standardising adverse event reporting in testosterone trials.
Basaria S
Evid Based Med; 2014 Feb; 19(1):32-3. PubMed ID: 23863945
[No Abstract] [Full Text] [Related]
14. Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care.
Górriz JL; Cos Claramunt FX; Duque N; Matali A
Prim Care Diabetes; 2019 Dec; 13(6):485-494. PubMed ID: 31400992
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
Pogue J; Walter SD; Yusuf S
Clin Trials; 2009 Jun; 6(3):239-51. PubMed ID: 19528133
[TBL] [Abstract][Full Text] [Related]
16. Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention population.
Sud M; Chu A; Austin PC; Naimark DM; Thanassoulis G; Wijeysundera HC; Ko DT
Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):427-434. PubMed ID: 35904312
[TBL] [Abstract][Full Text] [Related]
17. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
Herrmann J; Lenihan D; Armenian S; Barac A; Blaes A; Cardinale D; Carver J; Dent S; Ky B; Lyon AR; López-Fernández T; Fradley MG; Ganatra S; Curigliano G; Mitchell JD; Minotti G; Lang NN; Liu JE; Neilan TG; Nohria A; O'Quinn R; Pusic I; Porter C; Reynolds KL; Ruddy KJ; Thavendiranathan P; Valent P
Eur Heart J; 2022 Jan; 43(4):280-299. PubMed ID: 34904661
[TBL] [Abstract][Full Text] [Related]
18. Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.
Overton ET; Kitch D; Benson CA; Hunt PW; Stein JH; Smurzynski M; Ribaudo HJ; Tebas P
Clin Infect Dis; 2013 May; 56(10):1471-9. PubMed ID: 23386631
[TBL] [Abstract][Full Text] [Related]
19. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
Mehran R; Rao SV; Bhatt DL; Gibson CM; Caixeta A; Eikelboom J; Kaul S; Wiviott SD; Menon V; Nikolsky E; Serebruany V; Valgimigli M; Vranckx P; Taggart D; Sabik JF; Cutlip DE; Krucoff MW; Ohman EM; Steg PG; White H
Circulation; 2011 Jun; 123(23):2736-47. PubMed ID: 21670242
[No Abstract] [Full Text] [Related]
20. Oral Health and Cardiovascular Disease: Mapping Clinical Heterogeneity and Methodological Gaps.
Aldossri M; Farmer J; Saarela O; Rosella L; Quiñonez C
JDR Clin Trans Res; 2021 Oct; 6(4):390-401. PubMed ID: 32886582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
